An advisory committee for the FDA unanimously voted last week to support a nonprescription version of Narcan's nasal spray. But the list price could still pose a barrier.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
